Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
3
×
national blog main
national top stories
sanofi
3
×
clinical trials
san francisco blog main
san francisco top stories
2019
activism
acute hepatic porphyria
allosteric
alnylam pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
bernie sanders
boston
boulder/denver blog main
boulder/denver top stories
brace pharma
bristol-myers squibb
buyout
cancer
cancer drugs
celgene
charges
cleva pharma
colorectal cancer
congress
crisis
deals
detroit blog main
detroit top stories
drug discovery
drug prices
dupilumab
easl
What
disease
3
×
medicines
address
adds
advanced
ago
allosteric
alnylam’s
approval
bff
bio
cancer
cancer’s
clinic
conference
deals
devoted
drug
easl
elusive
form
frontiers
gene
hotspot
ipo
kicked
known
liver
major
maps
molecules
new
parlance
path
pharmaceutical
play
potential
proteins
race
reach
Language
unset
Current search:
sanofi
×
disease
×
" life sciences "
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
